Statera Biopharma, Inc. to Participate in the Benzinga Healthcare Small Cap Conference

September 29 - September 30, 2021

Statera Biopharma, Inc. (Nasdaq: STAB), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, will participate in the Benzinga Virtual Healthcare Small Cap Conference taking place September 29-30, 2001. Michael K. Handley, President and Chief Executive Officer of Statera, will provide an overview of the company on Wednesday, September 29, 2021.

Live Stream available starting 9-29 at 9:25AM EST.

Supporting Materials